Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.
Front Endocrinol (Lausanne). 2023 Feb 27;14:1095440. doi: 10.3389/fendo.2023.1095440. eCollection 2023.
Carbohydrate response element binding protein (ChREBP) is a glucose responsive transcription factor recognized by its critical role in the transcriptional control of glycolysis and lipogenesis. Substantial advances in the field have revealed novel ChREBP functions. Indeed, due to its actions in different tissues, ChREBP modulates the inter-organ communication through secretion of peptides and lipid factors, ensuring metabolic homeostasis. Dysregulation of these orchestrated interactions is associated with development of metabolic diseases such as type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). Here, we recapitulate the current knowledge about ChREBP-mediated inter-organ crosstalk through secreted factors and its physiological implications. As the liver is considered a crucial endocrine organ, we will focus in this review on the role of ChREBP-regulated hepatokines. Lastly, we will discuss the involvement of ChREBP in the progression of metabolic pathologies, as well as how the impairment of ChREBP-dependent signaling factors contributes to the onset of such diseases.
碳水化合物反应元件结合蛋白(ChREBP)是一种葡萄糖反应性转录因子,其在糖酵解和脂生成的转录控制中具有关键作用而被广泛认可。该领域的大量进展揭示了 ChREBP 的新功能。事实上,由于其在不同组织中的作用,ChREBP 通过分泌肽和脂质因子来调节器官间的通讯,从而确保代谢平衡。这些协调相互作用的失调与代谢疾病的发展有关,如 2 型糖尿病(T2D)和非酒精性脂肪性肝病(NAFLD)。在这里,我们通过分泌因子概括了当前关于 ChREBP 介导的器官间串扰及其生理意义的知识。由于肝脏被认为是一个重要的内分泌器官,我们将在这篇综述中重点关注 ChREBP 调节的肝因子的作用。最后,我们将讨论 ChREBP 在代谢病理进展中的作用,以及 ChREBP 依赖性信号因子的损伤如何导致这些疾病的发生。